CCL Products Approves Unaudited Financial Results for Quarter Ended June 30, 2025
The financial results indicate positive growth, which is likely to have a moderate impact on the company's stock and investor confidence.
The company reported increased revenue and profit in both standalone and consolidated financial results compared to the previous year's corresponding quarter.
* CCL Products (India) Limited approved the unaudited standalone and consolidated financial results for the quarter ended 30th June 2025. * Standalone revenue from operations for the quarter ended June 30, 2025, was ₹53,481.08 Lakh compared to ₹43,159.80 Lakh for the quarter ended June 30, 2024. * Standalone net profit for the period was ₹3,136.18 Lakh for the quarter ended June 30, 2025, compared to ₹2,514.20 Lakh for the quarter ended June 30, 2024. * Consolidated revenue from operations for the quarter ended June 30, 2025, reached ₹1,05,563.89 Lakh compared to ₹77,329.36 Lakh for the quarter ended June 30, 2024. * Consolidated net profit for the quarter was ₹7,244.86 Lakh, compared to ₹7,147.02 Lakh for the quarter ended June 30, 2024. Consolidated results include CCL and its 5 subsidiaries.
What to do with a filing like this
CCL Products (India) Limited filed this with the NSE as a statutory disclosure, categorised under results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by CCL Products (India) Limited. Read the original for the full detail.